miR-1207-5p suppresses lung cancer growth and metastasis by targeting CSF1

Area of Science:

• Molecular Biology
• Oncology
• Immunology

Background:

• MicroRNA-1207-5p was previously shown to inhibit epithelial-mesenchymal transition (EMT) but its mechanism remained unclear.
• Colony Stimulating Factor 1 (CSF1) is crucial for macrophage regulation and promotes pro-inflammatory chemokine release.

Purpose of the Study:

• To elucidate the mechanism by which miR-1207-5p inhibits lung cancer.
• To identify CSF1 as a direct target of miR-1207-5p.
• To investigate the role of the miR-1207-5p-CSF1 axis in lung cancer development and the tumor microenvironment.

Main Methods:

• In vitro studies using A549 lung cancer cells and HUVECs.
• In vivo studies using a nude mouse xenograft model.
• Analysis of lung cancer tissue microarrays to assess miR-1207-5p and CSF1 expression in relation to patient survival and metastasis.

Main Results:

• miR-1207-5p directly targets CSF1, inhibiting lung cancer cell proliferation, migration, and invasion.
• miR-1207-5p suppressed STAT3 and AKT signaling pathways.
• Overexpression of miR-1207-5p promoted HUVEC angiogenesis and modulated macrophage M2 phenotype.
• miR-1207-5p significantly inhibited A549 cell metastasis in vivo.
• A negative correlation between miR-1207-5p and CSF1 expression was observed in lung cancer tissues.

Conclusions:

• The miR-1207-5p-CSF1 axis is a novel regulator of lung cancer progression.
• This axis modulates the tumor microenvironment by influencing macrophage phenotype and function.
• Targeting the miR-1207-5p-CSF1 pathway may represent a new therapeutic strategy for lung cancer.